CN107952068A - A kind of anti-infective ointment of Traditional Chinese medicine probiotic - Google Patents

A kind of anti-infective ointment of Traditional Chinese medicine probiotic Download PDF

Info

Publication number
CN107952068A
CN107952068A CN201711422330.XA CN201711422330A CN107952068A CN 107952068 A CN107952068 A CN 107952068A CN 201711422330 A CN201711422330 A CN 201711422330A CN 107952068 A CN107952068 A CN 107952068A
Authority
CN
China
Prior art keywords
chinese medicine
bifidobacterium
ointment
infective
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711422330.XA
Other languages
Chinese (zh)
Inventor
彭光简
杨姝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711422330.XA priority Critical patent/CN107952068A/en
Publication of CN107952068A publication Critical patent/CN107952068A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001—Alpha-amylase (3.2.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses a kind of anti-infective ointment of Traditional Chinese medicine probiotic, is made of components such as medical ventolin, glucose, pearl powder, trehalose, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneols.The present invention is combined for Chinese medicine with probiotics, the utilization rate of Chinese medicine is effectively improved.According to tcm theory conditioning skin, the immunity and resistance of skin are improved, so as to strengthen resistance of the skin to germ, the adaptive faculty to external environment.Chinese medicine is combined with probiotics, improves the metabolism of skin.The anti-infective ointment of Traditional Chinese medicine probiotic provided by the invention, suppresses growth, the phagocytosis pathogenic bacteria of pathogenic bacteria, so as to prevent infection, utilizes Chinese medicine myogenic.Bactericidal antiphlogistic, clearing heat and detoxicating, analgesic effect is obvious, has the advantages that short treating period, quick, good effect, and is not recurred after rehabilitation, no sequel, is not easy to stay scar.

Description

A kind of anti-infective ointment of Traditional Chinese medicine probiotic
Technical field
The present invention relates to a kind of anti-infective ointment of Traditional Chinese medicine probiotic.
Background technology
Skin is first of human body immune defence line, and first of protective barrier of human body.Scald, acne rosacea, The skin diseases such as acne are often accompanied by injury redness cusalgia or blistering.After the wound healing controlled in existing Chinese traditional treatment method easily Leave the sequelae such as scar.For presently commercially available anti-infective ointment using antibiotic as main component, main principle is exactly to kill to cause Germ.But while killing pathogenic bacteria, substantial amounts of probiotics is also killed, these probiotics are that human body guards legion, are led The various functions such as skin metabolism and blood circulation are caused to reduce, skin is easy for becoming greyish black, dry, wrinkle increase, and presentation declines Old sign, or even suffer from dermatitis so that face and adornment area skin erythema, oedema, blister, papule, exudation, incrustation, itch, Pigmentation etc..And its treatment time of existing ointment is longer, it cannot effectively mitigate the feeling of pain of patient using process.
The content of the invention
To solve the above problems, the present invention provides a kind of anti-infective ointment of Traditional Chinese medicine probiotic, Chinese medicine is mutually tied with probiotics Close, the utilization rate of Chinese medicine is effectively improved.
The present invention is realized by following technical proposal：A kind of anti-infective ointment of Traditional Chinese medicine probiotic, by following weight percents Component composition：
Medical ventolin 3~4%, glucose 8~12%, pearl powder 2.5~3.5%, trehalose 4~6%, garden burnet 4~6%, myrrh 0.8~1.2%, frankincense 0.8~1.2%, pseudo-ginseng 4~6%, short-pedicel aconite root 4~6%, borneol 0.8~1.2%, dragon's blood 4~6%, male Red oil 0.8~1.2%, water 27.7~51.3%, neem oil 0.8~1.2%, eucalyptus oil 0.8~1.2%, Bacillus acidi lactici 0.8~1.2%, Bifidobacterium 0.8~1.2%, bifidobacterium longum 0.8~1.2%, bifidobacterium bifidum 0.8~1.2%, bifidobacterium catenulatum 0.8~ 1.2%th, Lactobacillus casei 0.8~1.2%, Lactobacillus Jensenii 0.8~1.2%, galactococcus 0.8~1.2%, intermediary streptococcus 0.8~ 1.2%th, proteinase-10 .8~1.2%, lactase 0.8~1.2%, lipase 0.8~1.2%, alpha-amylase 0.8~1.2%；It is above-mentioned each The summation of component is 100%.
Another object of the present invention is to provide a kind of preparation method of the anti-infective ointment of Traditional Chinese medicine probiotic, by following each Step：
（1）Component stock according to the following percentages by weight：
Medical ventolin 3~4%, glucose 8~12%, pearl powder 2.5~3.5%, trehalose 4~6%, garden burnet 4~6%, myrrh 0.8~1.2%, frankincense 0.8~1.2%, pseudo-ginseng 4~6%, short-pedicel aconite root 4~6%, borneol 0.8~1.2%, dragon's blood 4~6%, male Red oil 0.8~1.2%, water 27.7~51.3%, neem oil 0.8~1.2%, eucalyptus oil 0.8~1.2%, Bacillus acidi lactici 0.8~1.2%, Bifidobacterium 0.8~1.2%, bifidobacterium longum 0.8~1.2%, bifidobacterium bifidum 0.8~1.2%, bifidobacterium catenulatum 0.8~ 1.2%th, Lactobacillus casei 0.8~1.2%, Lactobacillus Jensenii 0.8~1.2%, galactococcus 0.8~1.2%, intermediary streptococcus 0.8~ 1.2%th, proteinase-10 .8~1.2%, lactase 0.8~1.2%, lipase 0.8~1.2%, alpha-amylase 0.8~1.2%；It is above-mentioned each The summation of component is 100%.
（2）Pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood are processed into nanometer through broken wall Level powder；
（3）By pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood, and medical ventolin, grape After sugar, trehalose, peony oil, water, neem oil, eucalyptus oil mixing, lactic acid bar, Bifidobacterium, bifidobacterium longum, not tally double is added Discrimination bacillus, bifidobacterium catenulatum, Lactobacillus casei, Lactobacillus Jensenii, galactococcus, intermediary streptococcus, protease, lactase, fat Fat enzyme, alpha-amylase, are left to ferment 30~180 days after mixing, organically combine each component, that is, it is anti-infective to obtain Traditional Chinese medicine probiotic Ointment.
Wherein, vaseline：With the effect for removing scar.Glucose：It is the indispensable battalion of metabolism in organism Support material.Pearl powder：Cure mainly：Solve the problems, such as face oil and dead skin, effect：Whitening, oil-control, anti-acne, pore cleanser, light spot, myogenic.Ground Elm：Nature and flavor：Picric acid；It is cold；It is nontoxic.Channel tropism：Liver；Lung；Kidney；Large intestine channel.Cure mainly：To spit blood, spitting of blood, bleeding from five sense organs or subcutaneous tissue, hematuria, has blood in stool, hemorrhoid blood, Bloody flux, uterine bleeding, leukorrhea with reddish discharge, sore, carbuncle and painful swelling, eczema, pruritus vulvae, scald, snakebite and bugbite.Effect：Cooling blood and hemostasis, heat-clearing solution Poison, healing up sore and subduing swelling.Myrrh：Nature and flavor：Hardship, it is pungent, put down.Channel tropism：Enter liver, spleen, the heart, kidney channel.Cure mainly：Traumatic injury, metal-inflicted wound, muscles and bones, The all pains of trusted subordinate, abdominal mass, Amenorrhea, ulcer sore pain, anal fistula, mesh barrier.Effect：Antibacterial, antimicrobial, anti-inflammatory, convergence, tool balosam are special Matter, deodorization, ventosity of dispelling, disinfection, diuresis, promoting menstruation, resolving sputum, killing fungus, excitation, sharp stomach, urge sweat, mend body, sharp uterus, control wound Wound, to it is ripe it is dry and cracked to take off coarse skin helpful.Frankincense：Nature and flavor：It is arduous, temperature.Channel tropism：Enter the heart, liver, the spleen channel.Cure mainly：Regulating the qi flowing in the channels Promoting blood circulation, analgesic therapy, chases after poison.Control qi and blood stagnation, trusted subordinate's pain, ulcerative carbuncle pyogenic infections, traumatic injury, dysmenorrhoea, postpartum blood stasis stabbing pain.Effect： There is more significant analgesic activity, be known as stronger strong bacteriostasis than a variety of antibacterials.Pseudo-ginseng：Nature and flavor：It is sweet；Slight bitter；It is warm-natured.Return liver Through；Stomach；The heart channel of Hang-Shaoyin；Lung channel；Large intestine channel.Cure mainly：Hemoptysis, spits blood, has blood in stool, uterine bleeding, traumatic hemorrhage；Treating swelling and pain by traumatic injury and Blood stasis. Effect：Removing blood stasis and hemostasis, analgesic therapy of invigorating blood circulation.Short-pedicel aconite root：Nature and flavor：It is bitter, acrid in flavour and warm in nature.Channel tropism：It is very toxic.Return liver warp.Attending effectiveness： Wind-damp dispelling, promoting blood circulation and stopping pain.Borneol：Nature and flavor：It is arduous, it is cool.Channel tropism：Enter the heart, lung channel.Cure mainly：Apoplexy lockjaw, pyreticosis coma, frightened epilepsy Phlegm confusing heart, deafness with qi stagnation, larynx numbness, aphtha, tympanitis, carbuncle swells, hemorrhoid, mesh also screen film, enterobiasis.Effect：Stagnated fire is dissipated, goes screen bright Mesh, swelling and pain relieving.Dragon's blood：Nature and flavor：It is sweet in flavor；It is salty；It is mild-natured；Mild toxicity.Channel tropism：The heart channel of Hang-Shaoyin；Liver Channel.Cure mainly：Traumatic injury；The internal injury stasis of blood Bitterly；Dysmenorrhoea；Postpartum stasis abdominal pain；Traumatic hemorrhage is more than；Scrofula；Ulcer on the shank is burst not to be conformed to and hemorrhoid long.Function：Scattered stasis pain；Hemostasis； Myogenic sore.Peony oil：There is fabulous Nutritional Nursing Care to act on skin, can obviously improve skin epidermal cells circulatory function, Promote the microcirculation of capillary of skin, the progress of anti-lipid peroxidation effect, improves metabolism, delaying skin declines Old process, there is crease-resistant, moisturizing whitening effect, light using rear skin smooth, to chloasma, skin aging wrinkle, skin keratin Hardening decortication, wrinkled skin, dry skin have certain therapeutic effect.Neem oil：For treating mange, pernio, promoting qi circulation and relieving pain, killing Worm, gastral cavity abdomen costalgia.Can antibacterium and virus, prevention infection.
The present invention possesses advantages below：The present invention is combined for Chinese medicine with probiotics, the utilization rate of Chinese medicine is obtained effectively Improve.According to tcm theory conditioning skin, the immunity and resistance of skin are improved, so as to strengthen resistance of the skin to germ Power, the adaptive faculty to external environment.Chinese medicine is combined with probiotics, improves the new old generation of skin.Chinese medicine benefit provided by the invention The raw anti-infective ointment of bacterium, suppresses growth, the phagocytosis pathogenic bacteria of pathogenic bacteria, so as to prevent infection, utilizes Chinese medicine myogenic.Sterilization disappears It is scorching, clearing heat and detoxicating, analgesic effect is obvious, there is short treating period, quick, good effect, and do not recurred after rehabilitation, without after Lose disease, do not stay scar.
Embodiment
Below by embodiment, the present invention will be further described.
Embodiment 1
（1）Component stock according to the following percentages by weight：
Medical ventolin 3%, glucose 8%, pearl powder 2.5%, trehalose 4%, garden burnet 4%, myrrh 0.8%, frankincense 0.8%, pseudo-ginseng 4%th, short-pedicel aconite root 4%, borneol 0.8%, dragon's blood 4%, peony oil 0.8%, water 51.3%, neem oil 0.8%, eucalyptus oil 0.8%, lactic acid bar Bacterium 0.8%, Bifidobacterium 0.8%, bifidobacterium longum 0.8%, bifidobacterium bifidum 0.8%, bifidobacterium catenulatum 0.8%, cheese breast bar Bacterium 0.8%, Lactobacillus Jensenii 0.8%, galactococcus 0.8%, intermediary streptococcus 0.8%, proteinase-10 .8%, lactase 0.8%, lipase 0.8%th, alpha-amylase 0.8%；The summation of above-mentioned each component is 100%.
（2）Pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood are processed into nanometer through broken wall Level powder；
（3）By pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood, and medical ventolin, grape After sugar, trehalose, peony oil, water, neem oil, eucalyptus oil mixing, lactic acid bar, Bifidobacterium, bifidobacterium longum, not tally double is added Discrimination bacillus, bifidobacterium catenulatum, Lactobacillus casei, Lactobacillus Jensenii, galactococcus, intermediary streptococcus, protease, lactase, fat Fat enzyme, alpha-amylase, are left to ferment 30 days after mixing, organically combine each component, that is, obtain the anti-infective ointment of Traditional Chinese medicine probiotic.
Embodiment 2
（1）Component stock according to the following percentages by weight：
Medical ventolin 4%, glucose 12%, pearl powder 3.5%, trehalose 6%, garden burnet 6%, myrrh 1.2%, frankincense 1.2%, pseudo-ginseng 6%th, short-pedicel aconite root 6%, borneol 1.2%, dragon's blood 6%, peony oil 1.2%, water 27.7%, neem oil 1.2%, eucalyptus oil 1.2%, lactic acid bar Bacterium 1.2%, Bifidobacterium 1.2%, bifidobacterium longum 1.2%, bifidobacterium bifidum 1.2%, bifidobacterium catenulatum 1.2%, cheese breast bar Bacterium 1.2%, Lactobacillus Jensenii 1.2%, galactococcus 1.2%, intermediary streptococcus 1.2%, protease 1.2%, lactase 1.2%, lipase 1.2%th, alpha-amylase 1.2%；The summation of above-mentioned each component is 100%.
（2）Pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood are processed into nanometer through broken wall Level powder；
（3）By pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood, and medical ventolin, grape After sugar, trehalose, peony oil, water, neem oil, eucalyptus oil mixing, lactic acid bar, Bifidobacterium, bifidobacterium longum, not tally double is added Discrimination bacillus, bifidobacterium catenulatum, Lactobacillus casei, Lactobacillus Jensenii, galactococcus, intermediary streptococcus, protease, lactase, fat Fat enzyme, alpha-amylase, are left to ferment 120 days after mixing, organically combine each component, that is, obtain Traditional Chinese medicine probiotic anti-infectious agent Cream.
Embodiment 3
（1）Component stock according to the following percentages by weight：
Medical ventolin 3.5%, glucose 10%, pearl powder 3%, trehalose 5%, garden burnet 5%, myrrh 1%, frankincense 1%, pseudo-ginseng 5%, snow Upper alpine yallow herb 5%, borneol 1%, dragon's blood 5%, peony oil 1%, water 39.5%, neem oil 1%, eucalyptus oil 1%, Bacillus acidi lactici 1%, Bifidobacterium 1%th, bifidobacterium longum 1%, bifidobacterium bifidum 1%, bifidobacterium catenulatum 1%, Lactobacillus casei 1%, Lactobacillus Jensenii 1%, milk-globule Bacterium 1%, intermediary streptococcus 1%, protease 1%, lactase 1%, lipase 1%, alpha-amylase 1%；The summation of above-mentioned each component is 100%。
（2）Pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood are processed into nanometer through broken wall Level powder；
（3）By pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood, and medical ventolin, grape After sugar, trehalose, peony oil, water, neem oil, eucalyptus oil mixing, lactic acid bar, Bifidobacterium, bifidobacterium longum, not tally double is added Discrimination bacillus, bifidobacterium catenulatum, Lactobacillus casei, Lactobacillus Jensenii, galactococcus, intermediary streptococcus, protease, lactase, fat Fat enzyme, alpha-amylase, are left to ferment 180 days after mixing, organically combine each component, that is, obtain Traditional Chinese medicine probiotic anti-infectious agent Cream.
The anti-infective ointment of Traditional Chinese medicine probiotic of above-described embodiment 1,2,3 is taken, for following therapeutic test：
First, subjects
Burned patient 100, patients with acne 100, acne rosacea patient 100.
Above-mentioned all kinds of cases are bisected into test group and each 150 of control group at random.
2nd, application method
Test group：The anti-infective ointment of Traditional Chinese medicine probiotic of the present invention is taken to be applied to affected part, it is 2-4 times daily, continuous 2 weeks, observation note Record result.
Control group：It is 2-4 times daily using conventional anti-inflammation antibacterial medicinal ointment purchased in market, continuous 2 weeks, observe and record result.
3rd, result
The anti-infective ointment clinical trial result of Traditional Chinese medicine probiotic provided by the invention：Test group reaches burned patient cure rate 97%, to the cure rate of patients with acne up to 98%, to acne rosacea patient cure rate up to 94%.
And control group is 12% to the effective percentage of burned patient, to patients with acne effective percentage up to 28%, to acne rosacea patient It is efficient up to 30%.
4th, conclusion
The present invention provides the anti-infective ointment of Traditional Chinese medicine probiotic and suppresses the growth of pathogenic bacteria, phagocytosis pathogenic bacteria, so that infection is prevented, profit With Chinese medicine myogenic, above-mentioned test group was fully recovered on 7th to 10, and bactericidal antiphlogistic, clearing heat and detoxicating, analgesic effect is obvious, and after observation It is better than control group without rebound phenomenon, its effect within continuous 2 months.
The anti-infective ointment of the Traditional Chinese medicine probiotic is combined for Chinese medicine with probiotics, the utilization rate of Chinese medicine is effectively carried It is high.The immunity and resistance of skin can be effectively improved, so as to strengthen resistance of the skin to germ, the adaptation to external environment Power, improves the new old generation of skin, has the advantages that short treating period, quick, good effect, and do not recurred after rehabilitation, no sequel, It is not easy to stay scar.Obtained product quality is stablized, and the shelf-life was up to 12 months, and easy to use, significant effect, quick, without bright Aobvious adverse reaction, safe without toxic side effect.

Claims (2)

1. a kind of anti-infective ointment of Traditional Chinese medicine probiotic, it is characterised in that comprise the following components in percentage by weight：
Medical ventolin 3~4%, glucose 8~12%, pearl powder 2.5~3.5%, trehalose 4~6%, garden burnet 4~6%, myrrh 0.8~1.2%, frankincense 0.8~1.2%, pseudo-ginseng 4~6%, short-pedicel aconite root 4~6%, borneol 0.8~1.2%, dragon's blood 4~6%, male Red oil 0.8~1.2%, water 27.7~51.3%, neem oil 0.8~1.2%, eucalyptus oil 0.8~1.2%, Bacillus acidi lactici 0.8~1.2%, Bifidobacterium 0.8~1.2%, bifidobacterium longum 0.8~1.2%, bifidobacterium bifidum 0.8~1.2%, bifidobacterium catenulatum 0.8~ 1.2%th, Lactobacillus casei 0.8~1.2%, Lactobacillus Jensenii 0.8~1.2%, galactococcus 0.8~1.2%, intermediary streptococcus 0.8~ 1.2%th, proteinase-10 .8~1.2%, lactase 0.8~1.2%, lipase 0.8~1.2%, alpha-amylase 0.8~1.2%；It is above-mentioned each The summation of component is 100%.
2. the preparation method of the anti-infective ointment of Traditional Chinese medicine probiotic described in claim 1, it is characterised in that pass through following each step：
（1）Component stock according to the following percentages by weight：
Medical ventolin 3~4%, glucose 8~12%, pearl powder 2.5~3.5%, trehalose 4~6%, garden burnet 4~6%, myrrh 0.8~1.2%, frankincense 0.8~1.2%, pseudo-ginseng 4~6%, short-pedicel aconite root 4~6%, borneol 0.8~1.2%, dragon's blood 4~6%, male Red oil 0.8~1.2%, water 27.7~51.3%, neem oil 0.8~1.2%, eucalyptus oil 0.8~1.2%, Bacillus acidi lactici 0.8~1.2%, Bifidobacterium 0.8~1.2%, bifidobacterium longum 0.8~1.2%, bifidobacterium bifidum 0.8~1.2%, bifidobacterium catenulatum 0.8~ 1.2%th, Lactobacillus casei 0.8~1.2%, Lactobacillus Jensenii 0.8~1.2%, galactococcus 0.8~1.2%, intermediary streptococcus 0.8~ 1.2%th, proteinase-10 .8~1.2%, lactase 0.8~1.2%, lipase 0.8~1.2%, alpha-amylase 0.8~1.2%；It is above-mentioned each The summation of component is 100%；
（2）Pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood are processed into nanoscale powder through broken wall Body；
（3）By pearl powder, garden burnet, myrrh, frankincense, pseudo-ginseng, short-pedicel aconite root, borneol and dragon's blood, and medical ventolin, grape After sugar, trehalose, peony oil, water, neem oil, eucalyptus oil mixing, lactic acid bar, Bifidobacterium, bifidobacterium longum, not tally double is added Discrimination bacillus, bifidobacterium catenulatum, Lactobacillus casei, Lactobacillus Jensenii, galactococcus, intermediary streptococcus, protease, lactase, fat Fat enzyme, alpha-amylase, are left to ferment 30~180 days after mixing, organically combine each component, that is, it is anti-infective to obtain Traditional Chinese medicine probiotic Ointment.
CN201711422330.XA 2017-12-25 2017-12-25 A kind of anti-infective ointment of Traditional Chinese medicine probiotic Pending CN107952068A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711422330.XA CN107952068A (en) 2017-12-25 2017-12-25 A kind of anti-infective ointment of Traditional Chinese medicine probiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711422330.XA CN107952068A (en) 2017-12-25 2017-12-25 A kind of anti-infective ointment of Traditional Chinese medicine probiotic

Publications (1)

Publication Number Publication Date
CN107952068A true CN107952068A (en) 2018-04-24

Family

ID=61955869

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711422330.XA Pending CN107952068A (en) 2017-12-25 2017-12-25 A kind of anti-infective ointment of Traditional Chinese medicine probiotic

Country Status (1)

Country Link
CN (1) CN107952068A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557278A (en) * 2004-02-04 2004-12-29 高春平 Skin, hair growth nutrient promotor
CN104274650A (en) * 2014-10-11 2015-01-14 苗志敏 Traditional Chinese medicine for treating skin burns and scalds
CN104958553A (en) * 2015-07-08 2015-10-07 曾德锋 Traditional Chinese medicine ointment for treating sore toxins and preparation method thereof
CN106420557A (en) * 2016-10-09 2017-02-22 上海兰葹生物科技有限公司 Herba dendrobii combined skin cream capable of promoting skin regeneration
CN106491975A (en) * 2016-11-30 2017-03-15 张本雨 A kind of Chinese medicinal ointment for treating abscess

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1557278A (en) * 2004-02-04 2004-12-29 高春平 Skin, hair growth nutrient promotor
CN104274650A (en) * 2014-10-11 2015-01-14 苗志敏 Traditional Chinese medicine for treating skin burns and scalds
CN104958553A (en) * 2015-07-08 2015-10-07 曾德锋 Traditional Chinese medicine ointment for treating sore toxins and preparation method thereof
CN106420557A (en) * 2016-10-09 2017-02-22 上海兰葹生物科技有限公司 Herba dendrobii combined skin cream capable of promoting skin regeneration
CN106491975A (en) * 2016-11-30 2017-03-15 张本雨 A kind of Chinese medicinal ointment for treating abscess

Similar Documents

Publication Publication Date Title
CN109078165A (en) A kind of composition and the preparation method and application thereof for the nursing of women privates
CN108434233A (en) A kind of Chinese medicine composition for preventing tinea pedis, the ringworm of the foot, pin sweat
CN102861151B (en) Traditional Chinese medicine compound for treating bedsores
CN101439114B (en) Chinese medicine for treating burn and scald, and preparation method thereof
CN105030620A (en) Moisturizing and acne removing facial cleanser and preparing method thereof
CN108295191A (en) A kind of acne-removing composition and preparation method thereof inhibiting Propiobacterium
CN107970201A (en) A kind of Traditional Chinese medicine probiotic beauty wash
CN101244109A (en) Natural Chinese medicine of oil-water liniment for treating burn and scald, and preparation thereof
CN101332271A (en) External medicine composition for treating burn and scald
CN105412415A (en) Medicine composition removing acnes
CN102552642A (en) Medicine which is used for treating acnes of young people and has skin whitening effect and preparation method thereof
CN107952068A (en) A kind of anti-infective ointment of Traditional Chinese medicine probiotic
KR20190098630A (en) Moisturing composition with improved moisturizing effect containing plants stem cell
CN105920334A (en) Chrysanthemum acne cream
CN105031170A (en) Healthcare foot bath powder and preparing method thereof
CN105168091A (en) Telangiectasis removing mask powder and preparation method thereof
CN111481612A (en) Self-heating essential oil patch for treating acute and chronic joint injury and muscle strain of human body and preparation method thereof
CN111184832A (en) Plant probiotic composition with functions of contracting vagina, lubricating, nourishing and protecting nests and preparation method thereof
CN1133456C (en) Liquid medicine for curing beriberi
CN104547989B (en) A kind of Tibetan medicine paste and its application method for being used to treat spondylodynia
CN104524056B (en) A kind of medicament of regional anesthesia analgesia and preparation method thereof
CN107096017A (en) Treat dermopathic external medicine composition and its application method
CN108403910A (en) A kind of tea medicine for treating eczema
CN107550985B (en) Traditional Chinese medicine formula containing roughhaired pine oil and preparation method thereof
CN106822300A (en) A kind of Chinese medicine preparation of anti-acne U.S. face

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180424

RJ01 Rejection of invention patent application after publication